Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma-Reference-Cited by-同舟云学术

Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma

Published:2022-09 Issue: Volume:153 Page:113465
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Hendrych Michal,Říhová Kamila,Adamová Barbora,Hradil Vojtěch,Stiborek Marek,Vlček Petr,Hermanová Markéta,Vašíčková Jana,Beneš Petr,Šmarda Jan,Kanický Viktor,Preisler Jan,Navrátilová Jarmila

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference73 articles.

1. Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo;Hickman;Biotechnol. J.,2014

2. Could 3D models of cancer enhance drug screening;Brancato;Biomaterials,2020

3. Ex vivo tumor culture systems for functional drug testing and therapy response prediction;Meijer;Future Sci. OA,2017

4. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery;Sivakumar;Oncoimmunology,2019

5. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuproptosis in cancers: Function and implications from bench to bedside;Biomedicine & Pharmacotherapy;2024-07

2. Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies;Clinical and Translational Medicine;2024-05-28

3. Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids;Biomedicine & Pharmacotherapy;2024-04

4. Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy;Journal of Experimental & Clinical Cancer Research;2024-01-23

5. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance;Drug Resistance Updates;2024-01